A Mass Balance Study of [14C]HRS-9057 for Injection in Healthy Participants
NCT07681479 · Status: NOT_YET_RECRUITING · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 6
Last updated 2026-07-02
Summary
This study is a single-center, open-label, single-dose phase I clinical trial. The trial is divided into four periods: screening, baseline, treatment, and follow-up
Conditions
- Fluid Retention Due to Heart Failure
Interventions
- DRUG
-
[14C]HRS-9057
\[14C\]HRS-9057
Sponsors & Collaborators
-
Fujian Shengdi Pharmaceutical Co., Ltd.
lead INDUSTRY
Study Design
- Allocation
- NA
- Purpose
- BASIC_SCIENCE
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 45 Years
- Sex
- MALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2026-07-31
- Primary Completion
- 2026-07-31
- Completion
- 2026-08-31
Countries
- China
Study Locations
More Related Trials
-
A Study of HRS-5632 in Adult Participants With Elevated Lipoprotein(a) at High Risk for Cardiovascular Events
NCT07185776 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Dose-comparison Study of Prednisone in Heart Failure
NCT01559727 ·Status: COMPLETED ·Phase: PHASE3
-
Enhancing the Natriuretic Peptide System in HFpEF
NCT05279742 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE1/PHASE2
-
A Dose-finding Study of OPC-41061 in Treatment of Cardiac Edema (Congestive Heart Failure)
NCT00234104 ·Status: COMPLETED ·Phase: PHASE2
-
HRS9531 Injection in Obese Subjects With Heart Failure With Preserved Ejection Fraction
NCT06391710 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
A Phase II Clinical Trial of HRS-1893 in the Treatment of Heart Failure With Preserved Ejection Fraction
NCT07269717 ·Status: RECRUITING ·Phase: PHASE2
-
A Clinical Study of HRS-7156 in Healthy Participants
NCT07601087 ·Status: RECRUITING ·Phase: PHASE1
-
An Investigational Study of Continuous 8-Hour Intravenous Administrations of BMS-986231 in Participants With Heart Failure and Reduced Heart Function Given a Standard Dose of Loop Diuretic
NCT03730961 ·Status: COMPLETED ·Phase: PHASE2
-
Dose Escalation Study of KW-3902 on Diuresis in Subjects With Congestive Heart Failure (CHF).
NCT00159627 ·Status: COMPLETED ·Phase: PHASE2
-
Real-world Research : Assessment of Effect of Combination of Drugs in the Treatment of Heart Failure
NCT06158711 ·Status: NOT_YET_RECRUITING
-
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
NCT07567001 ·Status: RECRUITING ·Phase: PHASE3
-
Study of Efficacy on NT-proBNP of Recombinant Human Neuregulin-1 in Chronic Heart Failure Patients
NCT01439789 ·Status: TERMINATED ·Phase: PHASE3
-
A Double-blind, Placebo-controlled Study of OPC-41061 in the Treatment of Cardiac Edema (Congestive Heart Failure)
NCT00462670 ·Status: COMPLETED ·Phase: PHASE3
-
Effects of Dapagliflozin on Cardiorespiratory Parameters in Heart Failure
NCT05770167 ·Status: UNKNOWN
-
Mobile Applet for Weight Management in Obese Heart Failure Patients
NCT06455878 ·Status: RECRUITING ·Phase: NA
-
Evaluation of the Effect of Injectable Neucardin on Cardiac Function and Reversal Ventricular Remodeling in Patients With Chronic Systolic Heart Failure
NCT05949801 ·Status: COMPLETED ·Phase: PHASE3
-
Product Design Clinical Performance Study of sc2Wear Furosemide Combination Product
NCT02804282 ·Status: COMPLETED ·Phase: PHASE3
-
A Trial of HRS-1893 in Healthy Volunteers and Patients With Obstructive Hypertrophic Cardiomyopathy
NCT05879523 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase III Trial of HRS-1893 in Patients With Obstructive Hypertrophic Cardiomyopathy
NCT07021976 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
A Study on Impact of Canagliflozin on Health Status, Quality of Life, and Functional Status in Heart Failure
NCT04252287 ·Status: COMPLETED ·Phase: PHASE3
-
Tezosentan in Acute Heart Failure
NCT00525707 ·Status: COMPLETED ·Phase: PHASE3
-
Translational and Clinical Aspects of Metabolic, Anabolic and Endothelial Dysfunction in Heart Failure
NCT05277415 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
ERtugliflozin triAl in DIabetes With Preserved or Reduced ejeCtion FrAcTion mEchanistic Evaluation in Heart Failure
NCT03416270 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of Tolvaptan in the Treatment of Cardiac-Induced Edema in Patients With Heart Failure
NCT01618448 ·Status: COMPLETED ·Phase: PHASE3
-
Dapagliflozin With or Without Spironolactone for HFpEF
NCT05676684 ·Status: COMPLETED ·Phase: PHASE2/PHASE3